ArticleInternational journal of pharmaceutics: X2026

A ROS-responsive nanozyme delivering gallic acid synergistically ameliorates chronic rhinosinusitis via epithelial barrier restoration and Syk/NF-κB inhibition.

Fangwei Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.